Baird Financial Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.1M Sell
38,193
-19,880
-34% -$10M 0.03% 394
2025
Q4
$27.1M Buy
58,073
+11,716
+25% +$5.44M 0.04% 293
2025
Q3
$19.8M Buy
46,357
+12,339
+36% +$4.78M 0.03% 376
2025
Q2
$13M Buy
34,018
+4,907
+17% +$1.77M 0.02% 465
2025
Q1
$10.1M Sell
29,111
-167
-0.6% -$53.7K 0.02% 513
2024
Q4
$8.79M Buy
29,278
+1,473
+5% +$515K 0.02% 541
2024
Q3
$11.3M Sell
27,805
-69
-0.2% -$25.3K 0.02% 475
2024
Q2
$8.96M Buy
27,874
+6,180
+28% +$2.01M 0.02% 514
2024
Q1
$7.24M Sell
21,694
-6,314
-23% -$1.93M 0.02% 566
2023
Q4
$7.58M Sell
28,008
-2,175
-7% -$538K 0.02% 541
2023
Q3
$7.42M Sell
30,183
-7,551
-20% -$2.07M 0.02% 510
2023
Q2
$11.5M Buy
37,734
+4,552
+14% +$1.27M 0.03% 412
2023
Q1
$8.75M Sell
33,182
-27,234
-45% -$6.92M 0.02% 459
2022
Q4
$14.5M Sell
60,416
-5,187
-8% -$1.16M 0.04% 359
2022
Q3
$12.1M Sell
65,603
-5,208
-7% -$1.04M 0.04% 382
2022
Q2
$11.9M Sell
70,811
-1,309
-2% -$281K 0.03% 401
2022
Q1
$18.1M Buy
72,120
+2,874
+4% +$722K 0.04% 332
2021
Q4
$17.8M Buy
69,246
+1,244
+2% +$304K 0.04% 341
2021
Q3
$16.5M Buy
68,002
+17,025
+33% +$4.16M 0.04% 334
2021
Q2
$10.5M Buy
50,977
+20,165
+65% +$4.11M 0.03% 417
2021
Q1
$5.8M Buy
30,812
+1,005
+3% +$177K 0.02% 535
2020
Q4
$4.9M Sell
29,807
-459
-2% -$67.1K 0.01% 552
2020
Q3
$3.77M Buy
30,266
+1,151
+4% +$142K 0.01% 562
2020
Q2
$2.83M Sell
29,115
-5,924
-17% -$616K 0.01% 633
2020
Q1
$3.15M Sell
35,039
-6,942
-17% -$899K 0.01% 552
2019
Q4
$6.21M Sell
41,981
-27,649
-40% -$3.71M 0.02% 486
2019
Q3
$8.38M Sell
69,630
-4,627
-6% -$598K 0.03% 384
2019
Q2
$10M Buy
74,257
+58,270
+364% +$7.37M 0.04% 354
2019
Q1
$2.08M Buy
15,987
+40
+0.3% +$5.37K 0.01% 652
2018
Q4
$1.99M Buy
15,947
+447
+3% +$60K 0.01% 631
2018
Q3
$2.17M Buy
15,500
+686
+5% +$85.4K 0.01% 640
2018
Q2
$1.52M Buy
14,814
+344
+2% +$34.8K 0.01% 728
2018
Q1
$1.4M Buy
14,470
+4,139
+40% +$402K 0.01% 733
2017
Q4
$907K Buy
+10,331
New +$830K 0.01% 843
2017
Q1
Sell
-4,535
Closed -$336K 1224
2016
Q4
$336K Sell
4,535
-14,330
-76% -$1.07M ﹤0.01% 1030
2016
Q3
$1.43M Sell
18,865
-6,194
-25% -$474K 0.01% 655
2016
Q2
$1.93M Sell
25,059
-947
-4% -$74.8K 0.02% 559
2016
Q1
$2.03M Sell
26,006
-966
-4% -$67.5K 0.02% 528
2015
Q4
$1.82M Sell
26,972
-2,430
-8% -$170K 0.02% 549
2015
Q3
$2.27M Buy
29,402
+23,565
+404% +$2.09M 0.02% 479
2015
Q2
$530K Buy
+5,837
New +$468K 0.01% 941

Other funds holding HCA

Baird Financial Group's HCA Position: Q1 2026 in Review

Baird Financial Group reduced its HCA Healthcare (HCA) stake by 34% in Q1 2026, selling an estimated $10M and leaving 38,193 shares worth $18.1M. The position accounts for 0.03% of the portfolio, ranked #394.

Baird Financial Group first reported a position in HCA in Q2 2015 and has held it in 41 quarters since. The position peaked at $27.1M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Baird Financial Group held 38,193 shares of HCA Healthcare worth $18.1M as of Q1 2026.
  • Baird Financial Group sold 19,880 HCA Healthcare shares in Q1 2026, an estimated $10M.
  • HCA Healthcare made up 0.03% of Baird Financial Group's portfolio in Q1 2026, its #394 holding.
  • Baird Financial Group first reported a position in HCA Healthcare in Q2 2015 and has held it in 41 quarters since.
  • Baird Financial Group's HCA Healthcare position peaked at $27.1M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.